SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008320
Filing Date
2024-05-15
Accepted
2024-05-15 17:21:11
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mtem-20240331x10q.htm   iXBRL 10-Q 1646530
2 EX-31.1 mtem-20240331xex31d1.htm EX-31.1 9801
3 EX-31.2 mtem-20240331xex31d2.htm EX-31.2 9775
4 EX-32.1 mtem-20240331xex32d1.htm EX-32.1 6878
5 GRAPHIC mtem-20240331x10q007.jpg GRAPHIC 58892
6 GRAPHIC mtem-20240331x10q008.jpg GRAPHIC 63912
  Complete submission text file 0001558370-24-008320.txt   7185169

Data Files

Seq Description Document Type Size
7 EX-101.SCH mtem-20240331.xsd EX-101.SCH 53435
8 EX-101.CAL mtem-20240331_cal.xml EX-101.CAL 48529
9 EX-101.DEF mtem-20240331_def.xml EX-101.DEF 187040
10 EX-101.LAB mtem-20240331_lab.xml EX-101.LAB 461704
11 EX-101.PRE mtem-20240331_pre.xml EX-101.PRE 349392
84 EXTRACTED XBRL INSTANCE DOCUMENT mtem-20240331x10q_htm.xml XML 1043615
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 24952638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)